Sedentary Status and Multidimensional Outcomes in Fibromyalgia
Comparison of Body Awareness, Respiratory Muscle Strength, Kinesiophobia, Central Sensitization, Functional Status and Sleep Quality in Sedentary and Non-Sedentary Fibromyalgia Individuals
1 other identifier
interventional
66
1 country
1
Brief Summary
Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and functional limitations. Pain, fatigue, and fear of movement often lead individuals with FMS to adopt sedentary behaviors, which may further exacerbate symptoms and reduce physical capacity. Factors such as impaired body awareness, reduced respiratory muscle strength, kinesiophobia, central sensitization, poor functional status, and sleep disturbances play an important role in disease severity and quality of life in individuals with FMS. Although physical inactivity is common in fibromyalgia, limited evidence exists regarding the differences in these multidimensional clinical parameters between sedentary and non-sedentary individuals with FMS. Therefore, the aim of this study is to compare body awareness, respiratory muscle strength, kinesiophobia, central sensitization, functional status, and sleep quality between sedentary and non-sedentary individuals diagnosed with fibromyalgia syndrome. The findings of this study may contribute to a better understanding of the impact of sedentary behavior on clinical outcomes in fibromyalgia and help guide more comprehensive and individualized rehabilitation approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedStudy Start
First participant enrolled
May 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2027
February 6, 2026
February 1, 2026
5 months
January 13, 2026
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
International Physical Activity Questionnaire (IPAQ) - Short Form
The International Physical Activity Questionnaire (IPAQ) is commonly used to assess physical activity. In this study, the 7-item short form of the IPAQ will be used. The questionnaire evaluates the number of days and duration over the past 7 days in which participants performed vigorous physical activity, moderate physical activity, and walking for at least 10 minutes per session. Total physical activity is calculated by multiplying the duration and frequency of each activity by its MET value: 8 MET for vigorous, 4 MET for moderate, and 3.3 MET for walking. Sedentary time is not included in the calculation. The weekly MET score is summed across all activities: \<600 MET-min/week is considered inactive, 601-3,000 MET-min/week moderately active, and \>3,000 MET-min/week active
Baseline
Mindful Attention Awareness Scale (MAAS)
The MAAS is a 15-item scale measuring the general tendency to be aware of and attentive to present-moment experiences. The scale is unidimensional, yielding a single total score, where higher scores indicate greater mindfulness. Items are rated on a 6-point Likert scale from 1 (almost always) to 6 (almost never).
Baseline
Postural Awareness Scale (PAS)
The Postural Awareness Scale evaluates individuals' postural awareness and efforts to regulate their posture. It consists of two factors and a total of 11 items. Total scores range from 11 to 77, with higher scores indicating better postural awareness.
Baseline
Fibromyalgia Impact Questionnaire (FIQ)
The Fibromyalgia Impact Questionnaire (FIQ) assesses functional status in fibromyalgia patients. The FIQ evaluates 10 domains: physical function, feeling well, work difficulty, work missed, pain, fatigue, morning tiredness, stiffness, anxiety, and depression. Excluding the "feeling well" domain, lower scores indicate better function. The questionnaire is patient-reported and takes approximately 5 minutes to complete, with a total score of 100. Physical Function Subscale: 11 questions scored 0-3, summed and averaged, then multiplied by 3.33 (range 0-33).Feeling Well Subscale: Reverse-scored, average multiplied by 1.43 (range 0-7).Work Missed Subscale: Directly scored, multiplied by 1.43. Other domains: Scored 0-10 per item; higher scores indicate greater impairment. All scores are summed to obtain a total FIQ score.
Baseline
Tampa Scale of Kinesiophobia (TSK)
The Tampa Scale for Kinesiophobia (TSK) was originally developed to assess fear of movement. The scale has 17 items, rated on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree). Items 4, 8, 12, and 16 are reverse-scored. Higher total scores indicate higher kinesiophobia.
Baseline
Central Sensitization Inventory (CSI)
The CSI assesses symptoms related to central sensitization in individuals with chronic pain. It consists of two parts: Part A evaluates 25 somatic and psychosocial symptoms commonly associated with central sensitization; Part B identifies medical conditions known to be related to central sensitization (not scored). Total scores are out of 100, with ≥40 indicating the presence of central sensitization.
Baseline
Pittsburgh Sleep Quality Index (PSQI)
The PSQI is a 24-item self-report questionnaire evaluating sleep quality and disturbances. The first 19 items are self-rated, and the remaining 5 are answered by a partner or roommate but are not included in scoring. Higher total scores indicate worse sleep quality. Seven subcomponents are scored 0-3: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Total scores range from 0-21; scores ≥5 indicate poor sleep quality
Baseline
Respiratory Muscle Strength Assessment
Respiratory muscle strength will be measured using the Cosmed Pony FX spirometer. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) will be assessed. MIP: Participant performs maximal expiration in a seated position, followed by maximal inspiration against a closed airway for 1-3 seconds. MEP: Participant performs maximal inspiration, followed by maximal expiration against a closed airway for 1-3 seconds. Three measurements will be taken, and the best value will be recorded. Age- and sex-specific reference values will be used.
Baseline
Study Arms (2)
Sedentary Fibromyalgia Group
OTHERIndividuals diagnosed with fibromyalgia syndrome who meet the criteria for sedentary behavior.
Non-Sedentary Fibromyalgia Group
OTHERIndividuals diagnosed with fibromyalgia syndrome who do not meet the criteria for sedentary behavior.
Interventions
No therapeutic intervention will be applied in this study. Participants will undergo a comprehensive assessment to evaluate clinical and functional characteristics. Assessments will include body awareness, respiratory muscle strength, kinesiophobia, central sensitization, functional status, sleep quality, and physical activity level. All evaluations will be conducted at a single time point using validated clinical measurement tools and self-reported questionnaires. The purpose of these assessments is to compare sedentary and non-sedentary individuals with fibromyalgia syndrome in terms of multidimensional clinical outcomes.
Eligibility Criteria
You may qualify if:
- Physical activity level below 600 MET-min/week according to the International Physical Activity Questionnaire (IPAQ)
- Diagnosis of fibromyalgia according to the 2016 ACR criteria
- Age between 18 and 65 years
- Ability to understand and respond to study assessments
You may not qualify if:
- Conditions posing risk during assessments, including unstable angina, decompensated heart failure, or myocardial infarction within the past month
- Uncontrolled diabetes, hypertension \>180/110 mmHg, and/or severe neuropathy
- Diagnosed severe cognitive impairment
- Physical activity level above 600 MET-min/week according to the IPAQ
- Diagnosis of fibromyalgia according to the 2016 ACR criteria
- Age between 18 and 65 years
- Ability to understand and respond to study assessments
- Conditions posing risk during assessments, including unstable angina, decompensated heart failure, or myocardial infarction within the past month
- Uncontrolled diabetes, hypertension \>180/110 mmHg, and/or severe neuropathy
- Diagnosed severe cognitive impairment
- Pregnancy or suspected pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Betül TAŞPINAR
Konak, İ̇zmi̇r, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Onur Engin, Asst.Prof.
Izmir Democracy University
- PRINCIPAL INVESTIGATOR
Ayşe Sezgi Kızılırmak Karataş, Asst.Prof
Izmir Democracy University
- PRINCIPAL INVESTIGATOR
Büşra Aydın, std.
Izmir Democracy University
- PRINCIPAL INVESTIGATOR
Öykü Dündar, std.
Izmir Democracy University
- PRINCIPAL INVESTIGATOR
Turna Sümen, std.
Izmir Democracy University
- PRINCIPAL INVESTIGATOR
Nalan Anık, std.
Izmir Democracy University
- PRINCIPAL INVESTIGATOR
Kader İliman, std.
Izmir Democracy University
- PRINCIPAL INVESTIGATOR
Fadıma Kılıç, std.
Izmir Democracy University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.Dr.
Study Record Dates
First Submitted
January 13, 2026
First Posted
January 22, 2026
Study Start
May 15, 2026
Primary Completion (Estimated)
October 15, 2026
Study Completion (Estimated)
January 15, 2027
Last Updated
February 6, 2026
Record last verified: 2026-02